Novo Nordisk CEO Lars Fruergaard Jørgensen weighs in the company's latest obesity drug offering, including its new oral ...

Presenter: Motti Farbstein, Chief Executive & Chief Financial Officer ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Novo Nordisk's Karsten Munk Knudsen is targeting 800 million obese people globally.

Novo Nordisk (NVO) said on Wednesday that its emissions rose by nearly a quarter in 2024 and will continue to increase up to ...

Access to healthy food would address the rising rates of obesity, diabetes and heart disease and the psychological issues ...

The weight loss injection Mounjaro is a new treatment that can now be delivered to customers' homes by a new clinic service offered by Morrisons.

Novo Nordisk reported turnover from obesity treatments soared by 57 per cent to 65.1 billion Danish kroner last year, largely ...

Both high-protein and low-carb diets are effective for weight loss. Consuming more protein may be the most important factor ...

Novo Nordisk said on Wednesday it plan to file its experimental next-generation obesity drug CagriSema for regulatory ...

LONDON/COPENHAGEN (Reuters) -Wegovy maker Novo Nordisk on Wednesday forecast slower sales growth for 2025 than 2024, a blow ...

El Paso, TX (KVIA-TV)-A new definition of obesity, published in the Lancet Diabetes and Endocrinology Journal, proposes a new definition that moves beyond body mass index (BMI). Dr. Jorge Acosta, the ...